Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|December 30, 2015
Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1G L Drusano, Arnold Louie, Alasdair MacGowan, et al.
Plos One|May 20, 2022
Emulating the MERINO randomised control trial using data from an observational cohort and trial of rapid diagnostic (BSI-FOO)Rebecca N Evans, Jessica Harris, Chris A Rogers, et al.
BMJ Open|May 4, 2019
Challenges and opportunities for involving patients and the public in acute antimicrobial medicine development research: an interview studyAndy Gibson, Michele Kok, David Evans, et al.
Neurourology and Urodynamics|May 16, 2017
The use of intravesical gentamicin to treat recurrent urinary tract infections in lower urinary tract dysfunctionPaul Abrams, Hashim Hashim, Charles Tomson, et al.
Journal of Clinical Pathology|March 6, 2007
Problems of basing patient recruitment for primary care studies on routine laboratory submissionsCliodna McNulty, Michael Thomas, Rhiannon John, et al.
BMJ Open|October 19, 2021
Cost-effectiveness of rapid laboratory-based mass-spectrometry diagnosis of bloodstream infection: evidence from the RAPIDO randomised controlled trialPadraig Dixon, William Hollingworth, Katie Pike, et al.
The Journal of Antimicrobial Chemotherapy|May 7, 2004
Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance ProgrammeRosy Reynolds, Nicola Potz, Melissa Colman, et al.
Jac-Antimicrobial Resistance|July 17, 2025
Development of antibacterial drug + bacteriophage combination assaysMarie Attwood, Pippa Griffins, Alan Noel, et al.
The Journal of Antimicrobial Chemotherapy|May 16, 2025
In vitro activity of NOSO-502, a novel-action antimicrobial, against clinical strains of Enterobacterales including MDR strainsMarie L G Attwood, Alan Noel, Pippa Griffin, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|July 29, 2017
Extent, quality and impact of patient and public involvement in antimicrobial drug development research: A systematic reviewDavid Evans, Emma Bird, Andy Gibson, et al.
Pageof 8